Corbus Pharmaceuticals Holdings Inc (LTS:0SZI)
$ 15.78 -0.1019 (-0.64%) Market Cap: 195.36 Mil Enterprise Value: 39.61 Mil PE Ratio: 0 PB Ratio: 1.30 GF Score: 21/100

Corbus Pharmaceuticals Holdings Inc Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer and Fibrotic Diseases Corporate Call Transcript

Jun 01, 2021 / 12:30PM GMT
Release Date Price: $60.84 (-2.97%)
Operator

Hello, and welcome to the Corbus Pharmaceuticals Conference Call. (Operator Instructions) This conference is being recorded at the company's request and will be available at the company's website approximately 2 hours following the end of the call.

I would now like to turn the call to your host, Ted Jenkins, Senior Director, Investor Relations and Corporate Communications. Please go ahead, sir.

Ted Jenkins
Corbus Pharmaceuticals Holdings, Inc. - Senior Director of IR & Corporate Communications

Thank you, operator. Good morning, everyone. At this time, I'd like to remind our listeners that remarks made during this call may state management's intentions, hopes, beliefs, expectations or projections of the future. These are forward-looking statements that involve risks and uncertainties.

Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws.

These forward-looking statements are based on Corbus' current expectations and actual results could differ materially. As a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot